Antibiotic Developments
WHO Report Shows Increase in HIV Drug Resistance to Dolutegravir
The World Health Organization’s (WHO) latest HIV Drug Resistance (HIVDR) Report tells us where drug resistance is growing and offers recommendations for countries to monitor and respond to the potential challenges. Read more
8 Mar 2024
SIRIO Launches New Consumer Health Gummies at CPHI Barcelona
Sirio Pharma will further expand its offering in the consumer health market, building on last month’s ‘pharma targeted’ softgel launch, with the introduction of a range of herbal gummies for trending consumer health categories. Read more
6 Oct 2023
ANL and SoundCell awarded grant for antibiotic sensitivity test
Applied Nanolayers BV (ANL) and SoundCell BV have received €275,000 R&D funding from Provincie Zuid-Holland to develop a prototype for SoundCell’s high throughput single-cell graphene antibiotic sensitivity test. Read more
27 Mar 2023
Accelerate Diagnostics announces CE marking of its antimicrobial kit
Accelerate Diagnostics, an in-vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis, announces CE marking of its new Accelerate Arc Module and BC kit. Read more
8 Aug 2022
Quidel Corp provides rapid clinical detection of C. difficile infection
The Sofia 2 C. difficile FIA (Fluorescent Immunoassay), from healthcare manufacturer Quidel Corporation, provides accurate detection of C. difficile in 15 minutes – half the time of comparator assays – allowing rapid treatment decisions. Read more
1 Jul 2022
Novasep and Paratek increase API manufacture for antibiotic
Technology supplier Novasep and Paratek Pharmaceuticals have signed an agreement to increase the commercial production of an active pharmaceutical ingredient (API) for an antibiotic. Read more
21 Feb 2022
The panel combatting the rise of antibiotic resistance in UTIs
Rebekah Jordan sits down with Oliver Schacht, CEO of OpGen, to discuss the increasing prevalence of antibiotic resistance in Urinary Tract Infections (UTIs), and how OpGen’s Unyvero can quicken the AR diagnosis process. Read more
11 Aug 2022
Antimicrobial resistance: Here we go again
Why we should pay attention to the latest antimicrobial resistance research. Read more
17 Feb 2022
The future of combatting antimicrobial resistance
Oliver Schacht, CEO of OpGen looks at why technologies including artificial intelligence and machine learning could be key to combatting antimicrobial resistance. Read more
29 Nov 2021
Biocomposites Confirms NanoBone UK Distribution
Containing the NanoBone SBX Putty and NanoBone QD solutions, NanoBone products aim to provide synthetic bone grafts for reliable, early osteogenesis and bone formation. Read more
13 Sep 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
OncoHost accepted to present poster at ESMO 2024
OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, has announced its selection to present a poster at the European Society of Medical Oncology (ESMO) Congress 2024. Read more
13 Sep 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
New collaboration set to integrate cryoFIL platform with Constellation robotic system
Cellular Origins has announced a collaboration with 3P innovation to integrate 3P's cryoFIL cryovial filling platform within Cellular Origins’ robotic system, Constellation, expanding the system’s capabilities by enabling automated filling Read more
12 Sep 2024
Pharma Manufacturing News + Pharmaceutical Manufacturing News
Arrowhead Pharmaceuticals’ Plozasiran Receives Breakthrough Therapy Designation from the FDA
The treatment has the potential to reduce triglycerides and other atherogenic lipoproteins. Read more
12 Sep 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
BGS Beta-Gamma-Service announces US expansion plans
BGS Beta-Gamma-Service, a specialist for more than 40 years in the use of beta and gamma rays for radiation sterilisation for medical devices, pharmaceutical packaging, and biotechnology products, will open its first facility in the United States. Read more
12 Sep 2024
ILC Therapeutics completes £2.5m financing round and bolsters C-suite
ILC Therapeutics, a specialist developer of hybrid interferons, a new drug class engineered for improved therapeutic profiles across multiple indications, has announced that it has successfully completed a fundraise of £2.5m. Read more
11 Sep 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Sponsored Content
Why Pharmaceutical Industry Needs a Digital Content Factory (DCF)?
Modern pharma brands pursue a higher degree of content personalisation to engage with diverse audiences. This means tighter deadlines, higher workloads, and a greater demand for skilled content creators than ever before. Read more